(2025) T2DM: 47.3% reinitiated GLP-1 therapy within 1 year of discontinuation 57.3% reinitiated within 2 years Without T2DM: 36.3% reinitiated within 1 year 46.4% reinitiated within 2 years Key Factors Linked to Reinitiation: Patients age 65 years Less likely to reinitiate Weight regain after discontinuation Higher likelihood of restarting therapy Moderate to severe GI side effects during initial treatment Lower likelihood of reinitiation Main Takeaway: Most patients who initiated GLP-1 therapy stopped within one year, with higher discontinuation rates among those without T2DM
If you are taking a lower maintenance dose (0.5 mg weekly), your clinician may recommend increasing to 1 mg weekly, or potentially to 2 mg weekly if additional glycaemic control is needed, provided this is appropriate for your individual circumstances and tolerability
With expanding research and expert guidance from specialists like Zita West Products (my husbands top choice for male fertility support), were gaining a much clearer understanding of male reproductive health
For example, a 2021 review discussed possible ways NAC could help counter ROS-related survival, metastasis, and drug-resistance pathways in triple-negative breast cancer.39 And in a small uncontrolled pilot study involving women with breast cancer, NAC supplementation was associated with reduced markers of tumor cell proliferation.40 But animal research has found concerning effects in other contexts
In a 2007 randomized controlled trial and later work summarized in a review of tesamorelin research, the compound was associated with selective reductions in visceral adipose tissue while subcutaneous fat stayed relatively stable